The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 21, 2026

Filed:

Nov. 20, 2020
Applicant:

The Charles Stark Draper Laboratory, Inc., Cambridge, MA (US);

Inventors:

Vishal Tandon, Somerville, MA (US);

Jeffrey Borenstein, West Roxbury, MA (US);

Jason Fiering, Somerville, MA (US);

Jenna Balestrini, Boston, MA (US);

Heena Mutha, Somerville, MA (US);

Jonathan Robert Coppeta, Windham, NH (US);

Mark Mescher, West Newton, MA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12M 1/42 (2006.01); B01L 3/00 (2006.01); C12M 1/00 (2006.01); C12M 1/26 (2006.01); C12M 1/36 (2006.01); C12N 5/078 (2010.01); C12N 5/0787 (2010.01);
U.S. Cl.
CPC ...
C12M 35/02 (2013.01); B01L 3/502761 (2013.01); B01L 3/502776 (2013.01); C12M 29/00 (2013.01); C12M 33/08 (2013.01); C12M 41/48 (2013.01); B01L 2300/0645 (2013.01); B01L 2400/0439 (2013.01); C12N 5/0634 (2013.01); C12N 5/0641 (2013.01); C12N 5/0642 (2013.01); C12N 2521/10 (2013.01);
Abstract

A system for cell bioprocessing and cell therapy manufacturing can include a series of microfluidic modules to enable continuous-flow end-to-end cell bioprocessing. Each module can implement a different technology, and the modules can be coupled to one another to perform various unit operations in the cell bioprocessing or cell-therapy manufacturing chain to enable direct processing of a blood or blood product sample. The system can automatically and continuously process the sample into genetically-modified lymphocytes or T cells for cellular therapy. The technologies implemented by each module in the system can include any combination of microfluidic acoustophoresis, microfluidic acoustophoretic media exchange or cell washing, and continuous-flow microfluidic electrotransfection. Modules implementing these microfluidic technologies can be interconnected with plastic tubing or with a custom manifold.


Find Patent Forward Citations

Loading…